July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
microRNA-1 regulates fibronectin expression in human trabecular meshwork cells under oxidative stress
Author Affiliations & Notes
  • Jiantao Wang
    Shenzhen Eye Hospital, Shenzhen, Guangzhou, China
  • Footnotes
    Commercial Relationships   Jiantao Wang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3511. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jiantao Wang; microRNA-1 regulates fibronectin expression in human trabecular meshwork cells under oxidative stress. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3511.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fibronectin has been demonstrated to be involved in the pathogenesis of glaucoma, meanwhile, microRNAs (miRs) may play an important role in this disease. However, the relationship of miR-1 and fibronectin in glaucoma still keeps unclear. The purpose of this study was to investigate whether miR-1 could regulate fibronectin in glaucoma.

Methods : The expression levels of fibronectin mRNA and miR-1 in human trabecular meshwork cells (HTMCs) under oxidative stress were evaluated by quantitative polymerase chain reaction (qPCR). Luciferase reporter assay and bioinformatics were used to test the target of miR-1. The effects of miR-1 on the fibronectin were assessed by qPCR, western blot and immunofluorescence technique.

Results : The mRNA level of fibronectin was increased, however, the expression level of miR-1 was downregulated in HTMCs under oxidative stress. MiR-1 targeted fibronectin through 3’-untranslated region (3’-UTR). Overexpression of miR-1 inhibited the expression of fibronectin in HTMCs under oxidative stress.

Conclusions : miR-1 could directly regulate the expression of fibronectin in HTMCs under oxidative stress, which may provide a novel therapeutic strategy in glaucoma.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×